Skip to main content
Clinician Reviews
ALL Specialities
ALL Specialities
/
Clinician Reviews
COVID-19 Updates
CE/CME
Cardiology
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology
Conference Coverage
Empagliflozin favorably reshaped left ventricles in HFrEF patients
Publish date:
November 15, 2020
FROM AHA 2020
mzoler@mdedge.com
Pages
« first
1
2
3
Recommended Reading
Dapagliflozin’s CKD performance sends heart failure messages
Clinician Reviews
Music’s charms may soothe heart failure’s effects
Clinician Reviews
The socioeconomic revolving door of 30-day heart failure readmissions
Clinician Reviews
Entresto halves renal events in preserved EF heart failure patients
Clinician Reviews
When should students resume sports after a COVID-19 diagnosis?
Clinician Reviews
Novel drug slows progression of diabetic kidney disease
Clinician Reviews
Updated heart failure measures add newer meds
Clinician Reviews
MADIT-CRT: Resynchronization linked to fewer heart failure hospitalizations
Clinician Reviews
New return-to-play recommendations for athletes with COVID-19
Clinician Reviews
No link shown between thyroid dysfunction and heart failure
Clinician Reviews
Cardiology
All Specialties
